Accessibility Menu
BetterLife Pharma logo

BetterLife Pharma

(OTC) BETRF

Current Price$0.04
Market Cap$6.89M
Since IPO (2010)-100%
5 Year-83%
1 Year-34%
1 Month-12%

BetterLife Pharma Financials at a Glance

Market Cap

$6.89M

Revenue (TTM)

CA$0.00

Net Income (TTM)

-CA$1.50M

EPS (TTM)

-$0.01

P/E Ratio

-5.84

Dividend

$0.00

Beta (Volatility)

0.33 (Low)

Price

$0.04

Volume

265,404

Open

$0.05

Previous Close

$0.04

Daily Range

$0.04 - $0.05

52-Week Range

$0.03 - $0.08

Estimated Earnings Date

May 29, 2026

BETRF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BetterLife Pharma

Industry

Pharmaceuticals

Employees

4

CEO

Ahmad Doroudian, PhD

Headquarters

Vancouver, BC V6H 1A6, CA

BETRF Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

26%

Return on Assets

-7%

Earnings Yield

-17.12%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.89M

Shares Outstanding

161.79M

Volume

265.40K

Avg. Volume

29.16K

Financials (TTM)

Gross Profit

CA$0.00

Operating Income

-CA$1.81M

EBITDA

-CA$1.81M

Operating Cash Flow

-CA$626.44K

Capital Expenditure

CA$5.46

Free Cash Flow

-CA$626.43K

Cash & ST Invst.

CA$12.59K

Total Debt

CA$906.42K

BetterLife Pharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

CA$0.00

N/A

Gross Profit

CA$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$6.89M

N/A

Market Cap/Employee

$984.59K

N/A

Employees

7

N/A

Net Income

-CA$381.15K

+48.2%

EBITDA

-CA$437.70K

+46.5%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Net Cash

-CA$893.83K

+30.9%

Accounts Receivable

CA$2.86K

-75.4%

Inventory

CA$0.00

N/A

Long Term Debt

CA$27.22K

-44.6%

Short Term Debt

CA$879.21K

-29.8%

Return on Assets

-6.80%

N/A

Return on Invested Capital

25.68%

N/A

Free Cash Flow

-CA$427.70K

-2128.9%

Operating Cash Flow

-CA$427.70K

-2128.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CPMVMosaic ImmunoEngineering Inc.
$0.67+0.00%
PHRRFPharmaTher Holdings Ltd.
$0.04-4.35%
BIXTBioxytran, Inc.
$0.03+2.67%
CUBTCurative Biotechnology, Inc.
$1.58+1.94%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$14.38-0.13%
TQQQProShares Trust - ProShares UltraPro Qqq
$73.05-0.14%
KEELKeel Infrastructure
$5.13-0.13%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$43.19+0.14%

Questions About BETRF

What is the current price of BetterLife Pharma?

BetterLife Pharma is trading at $0.04 per share.

What is the 52-week range for BetterLife Pharma?

Over the past 52 weeks, BetterLife Pharma has traded between $0.03 and $0.08.

How much debt does BetterLife Pharma have?

As of the most recent reporting period, BetterLife Pharma reported total debt of CA$668.31K.

How much cash does BetterLife Pharma have on hand?

BetterLife Pharma reported CA$9.28K in cash and cash equivalents in its most recent financial results.

What is BetterLife Pharma’s dividend yield?

BetterLife Pharma does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.